Welcure Drugs & Pharmaceuticals Ltd — Updates, 30-06-2025: Company Update

Welcure Drugs & Pharmaceuticals has announced new export sourcing orders worth approximately ₹85.6 Cr from Giant Exim and Ravina International for procurement and consolidation of mycorrhizal inoculant. These assignments will generate fee-based commission income without inventory or logistics risk, expected to boost margins in the current quarter. The company is also in advanced talks to secure additional export sourcing deals worth over ₹20 Cr this quarter. This development aligns with Welcure’s focus on expanding its fee-based export business while maintaining a debt-free capital structure.